Search Results

Baxter to Present at Citi's 2018 Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at Citi’s 2018 Global Healthcare Conference on Thursday, December 6, 2018, in New York. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 11:45 a.m. EST. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through March 7, 2019.

Flexibility That Works for Baxter Parents

At a time of changing family dynamics, we understand the increasing demands placed on our employees to balance their personal and work lives

Baxter Reports Third-Quarter 2018 Results and Updates Financial Outlook for Full-Year 2018

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2018 and updated its full-year 2018 financial outlook.

Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies

Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today the company received CE mark of both its PrisMax system and its TherMax blood warmer. PrisMax is the company’s next-generation technology for continuous renal replacement and organ support therapies.

Baxter Highlights Clinical Data at ASN: Kidney Week Showing How New Technologies are Advancing Dialysis Care Across Modalities

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, highlighted findings from HDx (expanded hemodialysis) and peritoneal dialysis (PD) studies presented at the American Society of Nephrology (ASN): Kidney Week, Oct. 23-28, showing how novel renal care technologies are positively impacting patient care and clinic efficiency.

'There Should Be No Barriers'

Born deaf, a Baxter employee climbs career ladder in a hearing world

Baxter Announces U.S. Regulatory Filing for PrisMax Acute Care System and Presentation of 15 Abstracts to Start ASN: Kidney Week 2018

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced it has submitted the PrisMax system for 510(k) clearance to the U.S. Food and Drug Administration (FDA).

Baxter to Showcase Critical Care Innovation at the 2018 European Society of Intensive Care Medicine Congress

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will highlight its latest innovations in critical care at the 2018 European Society of Intensive Care Medicine (ESICM) congress in Paris from Oct. 20-24.

Baxter and ASPEN Launch 'Smart PN' Tools to Reinforce Appropriate Use of Parenteral Nutrition

Today the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition, and Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, launched an educational video series on the appropriate use of parenteral nutrition (PN), as part of the organizations’ “SmartPN” collaboration to help reduce clinical malnutrition that was announced last year.

New Jersey Community Hospital First to See the Benefits of the New SPECTRUM IQ Infusion System

Baxter’s latest innovation in medication delivery showcases our commitment to advancing healthcare for patients and providers